Effects of Cerebrolysin on neuropsychiatric symptoms in Alzheimer's disease: results of a randomized, placebo-controlled trial

被引：0

作者：

Alvarez, A. ^{[1
]}

Cacabelos, R. ^{[1
]}

Couceiro, V. ^{[1
]}

Aleixandre, M. ^{[2
]}

Doppler, E. ^{[3
]}

Novak, P. ^{[3
]}

Moessler, H. ^{[3
]}

机构：

[1] EuroEspes Biomed Res Ctr, La Coruna, Spain

[2] Univ Granada, Sch Psychol, Granada, Spain

[3] EVER Neuro Pharma GmbH, Unterach, Austria

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2010年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：72 / 72

页数：1

共 50 条

[1] Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease
Furukawa, Katsutoshi
Tomita, Naoki
Uematsu, Daisuke
Okahara, Kazunori
Shimada, Hiroyuki
Ikeda, Masaki
Matsui, Toshifumi
Kozaki, Koichi
Fujii, Masahiko
Ogawa, Tatsuji
Umegaki, Hiroyuki
Urakami, Katsuya
Nomura, Hiroshi
Kobayashi, Naoto
Nakanishi, Aki
Washimi, Yukihiro
Yonezawa, Hisashi
Takahashi, Satoshi
Kubota, Masaharu
Wakutani, Yosuke
Ito, Daisuke
Sasaki, Takahiro
Matsubara, Etsuro
Une, Kaori
Ishiki, Aiko
Yahagi, Yukie
Shoji, Mikio
Sato, Hiroyasu
Terayama, Yasuo
Kuzuya, Masafumi
Araki, Nobuo
Kodama, Manabu
Yamaguchi, Takuhiro
Arai, Hiroyuki
GERIATRICS & GERONTOLOGY INTERNATIONAL, 2017, 17 (02) : 211 - 218
[2] Results of a randomized, double-blind, placebo-controlled trial with the neurotrophic compound cerebrolysin in Alzheimer's disease patients
Alvarez, A
Laredo, M
Sampedro, C
Cacabelos, R
Couceiro, V
Vargas, M
Aleixandre, M
Illescas, E
Linares, C
Granizo, E
Moessler, H
NEUROBIOLOGY OF AGING, 2004, 25 : S209 - S209
[3] Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent
M. Panisset
S. Gauthier
H. Moessler
M. Windisch
Journal of Neural Transmission, 2002, 109 : 1089 - 1104
[4] Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent
Panisset, M
Gauthier, S
Moessler, H
Windisch, M
JOURNAL OF NEURAL TRANSMISSION, 2002, 109 (7-8) : 1089 - 1104
[5] Cerebrolysin in Alzheimer's disease: A Randomized, Double-blind, Placebo-controlled Trial with a Neurotrophic Agent
Ruther, E.
Kasper, S.
Moessler, H.
JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (01) : 57 - 58
[6] Dose-response effects of cerebrolysin in Alzheimer's disease patients: A randomized, double-blind, placebo-controlled trial
Alvarez, XA
Cacabelos, R
Vargas, M
Aleixandre, M
Linares, C
Granizo, E
Moessler, H
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S383 - S383
[7] Combination Treatment in Alzheimer's Disease: Results of a Randomized, Controlled Trial with Cerebrolysin and Donepezil
Alvarez, X. A.
Cacabelos, R.
Sampedro, C.
Couceiro, V.
Aleixandre, M.
Vargas, M.
Linares, C.
Granizo, E.
Garcia-Fantini, M.
Baurecht, W.
Doppler, E.
Moessler, H.
CURRENT ALZHEIMER RESEARCH, 2011, 8 (05) : 583 - 591
[8] Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease
Herrmann, Nathan
Ruthirakuhan, Myuri
Gallagher, Damien
Verhoeff, Nicolaas Paul L. G.
Kiss, Alex
Black, Sandra E.
Lanctot, Krista L.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 27 (11): : 1161 - 1173
[9] A double-blind, placebo-controlled, multicenter study of cerebrolysin for Alzheimer's disease
Bae, CY
Cho, JY
Cho, KH
Oho, BH
Choi, KG
Lee, HS
Jung, SP
Kim, DH
Choi, KD
Cho, HS
Lee, HT
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S2 - S2
[10] Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease
Krishnan, KRR
Charles, HC
Doraiswamy, PM
Mintzer, J
Weisler, R
Yu, X
Perdomo, C
Ieni, JR
Rogers, S
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (11): : 2003 - 2011

← 1 2 3 4 5 →